論文・総説 - 梶原　道子

41. Shirahata A, Fujisawa K, Ishii E, Ohta S, Sako M, Takahashi Y, Taki M, Mimaya J, Kubota M, Miura T, Kitazawa J, Kajiwara M, Bessho F.. A nationwide survey of newly diagnosed childhood idiopathic thrombocytopenic purpura in Japan. J Pediatr Hematol Oncol.. 2009; 31 27-32.

42. Isoda T, Ito S, Kajiwara M, Nagasawa M.. Successful high-dose methotraxate chemotherapy in a patient with acute lymphoblastic leukemia who developed acute renal failure during the initial treatment. Pediatr Int.. 2007; 49 1018-1019.

43. Nagasawa N, Isoda T, Itoh S, Kajiwara M, Morio T, Shimizu N, Ogawa K, Nagata K, Nakamura N, Mizutani S.. Analysis of serum granulysin in patients with hematopoietic stem cell transplantation: its usefulness as a marker of graft-versus-host reaction. Am J Haematol.. 2006; 81 340-348.

44. Tsuji Y, Imai K, Kajiwara M, Aoki Y, Isoda T, Tomizawa D, Imai M, Ito S, Maeda H, Minegishi Y, Ohkawa H, Yata J, Sasaki N, Nagasawa M, Morio T, Nonoyama S, Mizutani S.. Hematopoietic stem cell transplantation for 30 patients with primary immunodeficiency diseases: 20 years experience of a single team. Bone Marrow Transpl.. 2006; 37 469-477.

45. Nagasawa N, Zhu Y, Isoda T, Tomizawa D, Itoh S, Kajiwara M, Morio T, Nonoyama S, Shimizu N, Mizutani S.. Analysis of serum soluble CD40 ligand (sCD40L) in the patients undergoing allogenic stem cell transplantation: platelet is a major source of sCD40L. Eur J Haematol.. 2005; 74 54-60.

46. Tomizawa D, Aoki Y, Nagasawa M, Morio T, Kajiwara M, Sekine T, Shimiau N, Kato M, Yachie A, Mizutani S.. Novel adopted immunotherapy for mixed chimerism after unrelated cord blood transplantation in Omenn syndrome. Eur J Haematol.. 2005; 75 441-444.

47. Tsuji Y, Ito S, Isoda T, Kajiwara M, Nagasawa M, Morio T, Mizutani S.. Successful nonmyeloablative cord blood transplantation for an infant with malignant infantile osteopetrosis. J Pediar Hematol Oncol.. 2005; 27 495-498.

48. Igarashi S, Manabe A, Ohara A, Kumagai M, Saito T, Okimoto Y, Kamijo T, Isoyama K, Kajiwara M, Sotomatsu M, Sugita K, Sugita K, Maeda M, Yabe H, Kinoshita A, Kaneko T, Hayashi Y, Ikuta K, Hanada R, Tsuchida M.. No advantage of dexamethasone over predonisolone for the outcome of standard- and intermediate-risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study Group L95-14 protocol. J Clin Oncol.. 2005; 23 6489-98.

49. Tomizawa D, Imai K, Ito S, Kajiwara M, Minegishi Y, Nagasawa M, Morio T, Nonoyama S, Mizutani S.. Allogenic hematopoietic stem cell transplantation for seven children with X-linked hyper-IgM syndrome: A single center experience. Am J Hematol. 76:33-39, 2004.. 2004; 76 33-39.

50. Imai.K, Morio T, Zhu Y, Jin Y, Itoh Y, Kajiwara M, Yata J, Mizutani S, Ochs H.D, Nonoyama S.. Clinical Course of patients with WASP mutations. Blood.. 2004; 10 456-464.

51. Nagasawa N, Tomizawa D, Tsuji Y, Kajiwara M, Morio T, Nonoyama S, Asada M, Mizutani S.. Pancytopenia presenting with monosomy 7 which disappeared after immunosuppressive therapy. 2004; 28 315-319.

52. Komatsu F, Hasegawa K, Yanagisawa Y, Kawabata T, Kaneko Y, Watanabe S, Miyagi S, Sakuma M, Kagawa Y, Kajiwara M.. Prevalence of diego blood group Dia antigen in Mongolians: comparison with that in Japanese. Transfus Apher Sci.. 2004; 30 119-124.

53. Komatsu F, Kajiwara M.. A pilot study of large volume apheresis of red blood cells and plasma during one donation by allogeneic blood donors. Transfus Sci.. 2000; 23 55-61.

54. Komatsu F, Kajiwara M.. CD18/CD54(+ CD102), CD2/CD58 pathway-independent killing of lymphokine-activated killer (LAK) cells against glioblastoma cell lines T98G and U373MG. Oncol Res.. 2000; 12 17-24.

55. Tsuchida M, Ikuta K, Hanada R, Saito T, Isoyama K, Sugita K, Toyoda Y, Manabe A, Koike K, Kinoshita A, Maeda M, Ishimoto K, Sato T, Okimoto Y, Kaneko T, Kajiwara M, Sotomatsu M, Hayashi Y, Hoshi Y, Ohira M, Bessho F, Tsunematsu Y, Tsukimoto I, Nakazawa S.. Long-term follow-up of childhood acute lymphoblastic leukemia in Tokyo Children's Cancer Study Group 181-1995. Leukemia.. 2000; 14 2295-2306.

56. Nagasawa M, Imai M, Imai K, Itoh S, Kajiwara M, Morio T, Nonoyama S.. In vivo class switch of B cells after cord blood stem cell transplantation in severe combined immune deficient (SCID) patient. Am J Hematol.. 2000; 65 176-177.

57. Kajiwara M, Nonoyama S, Eguchi M, Morio T, Imai K, Okawa H, Kaneko M, Sako M, Ohga S, Maeda M, Hibi S, Hashimito H, Shibuya A, Ochs HD, Nakahata T, Yata J.. WASP is involved in proliferation and differentiation of human haemopoietic progenitors in vitro. Br J Haematol.. 1999; 107 254-262.

58. Komatsu F, Kajiwara M.. A lymphokine-activated killer (LAK)- resistant cell line, and low expression of adhesion molecules LFA-3 and VCAM-1 on its cell surface. Oncol Res.. 1998; 10 263-269.

59. Komatsu F, Kajiwara M.. Timing of effective natural killer cell collection in cancer patients after high dose chemotherapy, comparing to peripheral blood stem cell collection. Ther Apher.. 1998; 2 277-282.

60. Komatsu F, Kajiwara M.. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class 1 antigens, adhesion molecules and Fas of target cells. Oncol Res.. 1998; 10 483-489.